Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Candesartan Cilexetil
Atacand · Candesartan cilexeti · Blopress · Candesartan cilexetil for peak identification · tcv116 · exetiL · TCY 116 · Candestartan

식별자 및 물리적 특성
| CAS No. | 145040-37-5 |
|---|---|
| 분자식 | C33H34N6O6 |
| 평균 분자량 | 610.7 g/mol |
| SMILES | CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 |
| InChIKey | GHOSNRCGJFBJIB-UHFFFAOYSA-N |
| PubChem CID | 2540 |
| ChEMBL | CHEMBL1014 |
| ChEBI | CHEBI:3348 |
| EC No. | 627-030-2 |
| DTXSID | DTXSID5020239 |
화학 및 물리적 성질
| XLogP | 7 |
|---|---|
| 극성 표면적 | 143 |
| 수소 결합 공여자 수 | 1 |
| 수소 결합 수용자 수 | 10 |
| 회전 가능 결합 수 | 13 |
| 무거운 원자 수 | 45 |
| 형식 전하 | 0 |
| 복잡도 | 962 |
| 의약품 | PharmaceuticalsPharmaceuticals -> Used in Switzerland |
| Human Drugs | FDA approved drugs -> Active ingredient |
| Collision Cross Section | 242.2 Ų [M+H]+ [CCS Type: DTBuffer gas: N2Ionization: ESI+Dataset: TOXCASTSource Identifier: DTXSID5020239]241.5 Ų [M+H]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards] |
| 녹는점 | 168-170C |
| 끓는 점 | 843.3±75.0 °C(Predicted) |
| 밀도 | 1.37±0.1 g/cm3(Predicted) |
| 저장 조건 | 2-8°C |
| 용해도 | DMSO: ≥15mg/mL |
| pKa(산도 계수) | pKa 3.55 (H2O t=25.0 I=0.025) (Uncertain)5.91(H2O t=25.0 I=0.025) (Uncertain) |
| 물리적 상태 | 가루 |
| 색상 | 흰색에서 베이지색 |
| Merck | 14,1739 |
| BCS Class | 2 |
| 주요 응용 | 의약품(소분자) |
| InChIKey | GHOSNRCGJFBJIB-UHFFFAOYSA-N |
| SMILES | C1(OCC)N(CC2=CC=C(C3=CC=CC=C3C3=NNN=N3)C=C2)C2=C(C(OC(OC(OC3CCCCC3)=O)C)=O)C=CC=C2N=1 |
화학적 성질
It appears as a white or off-white powder.It is soluble in methanol but insoluble in water.
안전 및 규제
| GHS 분류 | This chemical does not meet GHS hazard criteria for 0.5% (1 of 197) of reports.DangerH302 (26.9%): Harmful if swallowed [Warning Acute toxicity, oral]P203, P260, P261, P263, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 197 reports by companies from 20 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| Hazard Classes and Categories | Acute Tox. 4 (26.9%) |
| Drug Induced Liver Injury | Drug Induced Liver Injury Rank (DILIrank 2.0)Candesartan cilexetilvLess-DILI-concern3Adverse reactionsDOI:10.1016/j.drudis.2016.02.015 |
| 수질 위해 등급(WGK) | 3 |
| RTECS 번호 | DD6672500 |
| 독성 | dog,LD50,oral,> 2gm/kg (2000mg/kg),Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 42, Pg. 406, 2000. |
| 관세 코드 | 29339953 |
| 위험 문구(R) | 20/21/22-36/37/38-50-48/20-61 |
| 위험 표시 | Xn,N,T |
| 안전 문구(S) | 26-36-61-45-53 |
| 위험 등급 | Repr. 1BSTOT RE 2 Oral |
| 저장 분류 | 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects |
용도
일반 설명
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards